Genmab AS News
News
0
Ticker
GMAB
ISIN
US3723032062
Genmab AS Eulerpool News
Genmab AS Stock News
Genmab AS is being monitored by journalists and investors worldwide. We gather the latest Genmab AS news here.
- November 19·Benzinga
- November 9·SeekingAlpha
- November 6·Yahoo
- November 5·SeekingAlpha
- November 3·SeekingAlpha
- October 30·SeekingAlpha
- October 30·Benzinga
- October 29·SeekingAlpha
- October 29·Benzinga
- October 29·Benzinga
- October 29·Yahoo
- October 28·ChartMill
- October 28·ChartMill
- October 28·SeekingAlpha
- October 28·Benzinga
- October 28·Benzinga
- October 26·Yahoo
- October 26·Yahoo
- October 26·Yahoo
- October 26·Benzinga
Genmab AS Stock Press Releases
Genmab AS regularly publishes news on the company's website that are relevant for investors.
Genmab AS News 2026
This page contains all current news, analysis and press releases for Genmab AS stock (GMAB, ISIN: US3723032062). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Genmab AS.
Genmab AS Stock
Genmab AS Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions.